KBC Group
MRTX

KBC Group’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

KBC Group’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-955
Closed -$56K – 1902
2023
Q4 		$56K Hold
955
– – ﹤0.01% 1449
2023
Q3 		$42K Buy
+955
New +$42K ﹤0.01% 1596